FDA Approves Gene Therapy for Rare Muscular Dystrophy
The health regulator has granted accelerated approval to Sarepta Therapeutics' first-of-its-kind gene therapy for Duchenne muscular dystrophy.
Source: medscape.com
Sarepta Ingram News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sarepta Ingram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sarepta Ingram Today - Breaking & Trending Today
US FDA approves Sarepta's gene therapy for rare muscular dystrophy in some kids | WKZO | Everything Kalamazoo
By Leroy Leo and Aditya Samal (Reuters) -The U.S. Food and Drug Administration on Thursday granted accelerated approval to Sarepta Therapeutics' first...
Source: wkzo.com
US FDA approves Sarepta's gene therapy for rare muscular dystrophy in some kids
The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics' first-of-its-kind gene therapy for Duchenne muscular dystrophy (DMD), an inherited progressive muscle-wasting disorder that almost always affects young boys. Sarepta said on Thursday the Food and Drug Administration had approved the treatment for children aged between 4 and 5 years who can walk. It was initially seeking approval for all DMD patients who can walk.
Source: yahoo.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XUHLS6YD3ZJ7PL63YBYH4GUUCU.jpg)
US FDA approves Sarepta's gene therapy for rare muscular dystrophy in some kids
The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics' first-of-its-kind gene therapy for Duchenne muscular dystrophy (DMD), an inherited progressive muscle-wasting disorder that almost always affects young boys.
Source: reuters.com